Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
NuvOx Pharma Announces Issuance of a New Patent
NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof.” - May 19, 2022 - NuvOx Therapeutics
Intrinsica Announces Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge
Today, Intrinsica Inc., a non-profit organization, announced the dates for the RAPID Alliance 2.0 Launch Meeting and Innovation Acceleration Forum for solving a $528 billion dollar medications use challenge affecting 200 million or more people in the US. The event is occurring on June 21 and 22, 2022, virtually. The event is designed to bring together a select group of leaders, scholars, innovators, funders, technologists, government leaders and others from across the US medications sector. - May 13, 2022 - Intrinsica, Inc.
Dr. Pam Gumbs Named VIP Member for 2022 by Strathmore's Who's Who Worldwide Publication
Dr. Pam Gumbs of Berkeley, California has been named as a VIP Member by Strathmore’s Who’s Who Worldwide for 2022 for her outstanding contributions and achievement for over 40 years in the pharmaceutical field. About Dr. Pam Gumbs Dr. Pam Gumbs is the owner and CEO of United Pharmacy... - May 13, 2022 - Strathmore Worldwide
NuvOx Appoints Dr. Robert King to SAB
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, appointed Dr. Robert King to its Scientific Advisory Board (SAB). Dr. King is a seasoned life science executive with over 30 years’... - May 11, 2022 - NuvOx Therapeutics
Microvascular Therapeutics Finalizes Facility Certification for the Production of Its Product, MVT-100
Microvascular Therapeutics (MVT), a clinical stage biotechnology company, finalized its manufacturing facility certifications for the GMP production of its first product, MVT-100. - April 21, 2022 - Microvascular Therapeutics, Inc.
NuvOx Technology Featured in Prominent Peer Review Journal
NuvOx Pharma’s technology, which is developed as a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, was featured in the prominent journal of Frontiers of Neurology. - April 19, 2022 - NuvOx Therapeutics
NuvOx Finalizes Facility Certification, Poising for Phase IIb Trials
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, finalized its manufacturing facility certifications for Phase IIb trials. - April 17, 2022 - NuvOx Therapeutics
Governor Doug Ducey Signs SB1162 Into Law Helping Arizonans with Chronic Intractable Pain Get the Treatment They Need
Senator Nancy Barto introduced Arizona SB1162 in January 2022. This new law will give protections to chronic intractable pain patients in Arizona. This amendment to ARS Section 32-3248.01, will improve access to care, give physicians the ability to treat their patients as medically appropriate, and confirm that providers and their state governing boards have oversight on the proper treatment for these patients. - April 15, 2022 - International Pain Foundation
Best Medical Website to be Named by Web Marketing Association in 26th Annual WebAward Competition
The Web Marketing Association will name the best medical websites in the world as part of their 26th annual international WebAward Competition for Web site development. Medial Websites can be entered into consideration for the 2022 Best Medical Website and other medical-related WebAwards at www.webaward.org. - April 10, 2022 - Web Marketing Association
Microvascular Therapeutics Receives Funds from Commercialization Readiness Program for the Development of Its Ultrasound Contrast Agent, MVT-100
MicrovMicrovascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Commercialization Readiness Program grant from the National Institute of Heart, Lung, and Blood Institute (NHLBI). Wyatt Unger, MD, MBA, Chief Medical Officer of MVT said, “We are... - April 09, 2022 - Microvascular Therapeutics, Inc.
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks’ time on April 27th and 28th, 2022. - April 08, 2022 - SAE Media Group
Yavari LLC Earns NABP Drug Distributor Accreditation
Yavari LLC has earned Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®). NABP’s Drug Distributor Accreditation is a resource for industry and regulatory bodies that establish uniform safeguards meant to protect the public health. Drug... - April 03, 2022 - Yavari LLC
Pipelinepharma Marketplace Records Quadruple Growth Over a Single Year
The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. New finished dosage form categories for medical devices and nutraceuticals will also be launched in the coming months. - April 01, 2022 - Pipelinepharma
Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens
Creative Diagnostics recently launches a range of natural and recombinant staphylococcal enterotoxin antigens. - March 31, 2022 - Creative Diagnostics
Myra E. Clements, RPh Recognized as a Professional of the Year for 2022 by Strathmore's Who's Who Worldwide Publication
Myra E. Clements, RPh of Richmond, Virginia, has been recognized as a Professional of the Year for 2022 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievements in the healthcare field. About Myra E. Clements, RPH With over 40 years' experience, Ms. - March 30, 2022 - Strathmore Worldwide
VPL Launches Pharmacy Solution to Ensure Specialty Drugs are Delivered Cost Effectively & Securely
Built on proven technology, VPL provides a single platform for all health systems' supply chain needs. - March 16, 2022 - VPL
PurerVita Ltd. Launches UK First Revolutionary Supplements for Pregnancy and Postpartum Recovery
Launch of PurerMama, A positive impact nutritional and wellness brand by doctors at The Baby Show, Excel London. - March 12, 2022 - PurerVita UK Limited
Denver City and County Building Lights Red for Bleeding Disorders Awareness
The Denver City and County Building located at 1437 Bannock Street was lit in magnificent red lights the week of March 2-7 in honor of Bleeding Disorders Awareness Month (BDAM). With about 3 million people nationwide impacted, it is critical to bring awareness to the important health condition and to advocate for access to diagnosis and ongoing health care. - March 12, 2022 - National Hemophilia Foundation - Colorado Chapter
2022 Women in Oncology Awards
The Women in Oncology Awards are presented annually to outstanding women who have made remarkable contributions to the lives of those fighting cancer. The winners of the 2022 Women in Oncology Awards are Karen Kelly, MD, FASCO, Elizabeth A. Mittendorf, MD, PhD, and Rachna T. Shroff, MD, MS. - February 23, 2022 - Cancer Expert Now, Inc.
Cooperative Buying to Help Launch New Medicines in Small Markets
Large manufacturer minimum order quantities put specialist medicines out of reach of buyers in smaller markets. By grouping pharmaceutical orders from different buyers into a single collective bulk order, Pipelinepharma will help buyers to reach the minimum order quota. The initiative further builds upon Pipelinepharma’s mission to provide better access to medicines for patients all around the world. - February 17, 2022 - Pipelinepharma
Decarbitation Inc. Product Launch: New Cannabis Crude Oil Decarboxylation Technology Using Controlled Cavitation
DecarbitationTM will be launching its website as well brand new 2 and 25 gallon systems for the decarboxylation of cannabis on February 2, 2022. - February 01, 2022 - Decarbitation Inc.
‘Dr. Pam’ Gumbs Recognized as a Professional of the Year for 2021 by Strathmore's Who's Who Worldwide Publication
‘Dr. Pam’ Gumbs of Berkeley, California has been recognized as a Professional of the Year for 2021 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievement for over 40 years in the pharmaceutical field. About ‘Dr. Pam’ Gumbs Dr. Pam... - January 25, 2022 - Strathmore Worldwide
BOC Sciences Offers Pharmaceutical Impurities to Assist in Drug Development
BOC Sciences announces the provision of pharmaceutical impurities to assist in drug development. - January 09, 2022 - BOC Sciences
Exclusive Speaker Interview with Karen Capper, AstraZeneca Ahead of the Pharmaceutical Microbiology UK Virtual Conference
SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field. - January 08, 2022 - SAE Media Group
LifeTein Awarded the Fastest Peptide Synthesis Service in 2021
LifeTein was awarded the fastest peptide synthesis service in 2021 by New world Report, thanks to their speedy custom protein, antibody, and chemical services for biotech, pharma, academia, government customers, and diagnostics. Their services reach across the entire United States and more than 30 other nations. LifeTein provides the fastest turnaround time and most reliable quality in the industry, using their proprietary microwave-assisted heating technology for peptide synthesis. - January 07, 2022 - LifeTein
BOC Sciences Promotes Drug Development by Pharmaceutical Impurity Identification
BOC Sciences recently introduces pharmaceutical impurity identification services to accelerate drug development. - December 30, 2021 - BOC Sciences
‘Dr. Pam’ Gumbs Celebrated as a Woman of Empowerment by P.O.W.E.R.-Professional Organization of Women of Excellence Recognized
‘Dr. Pam’ Gumbs of Berkeley, California has been celebrated as a Woman of Empowerment by P.O.W.E.R.-Professional Organization of Women of Excellence Recognized for her outstanding contributions to the pharmaceutical field for over 40 years. About ‘Dr. Pam’ Gumbs For over 20... - December 22, 2021 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. - December 22, 2021 - SAE Media Group
Pharmaceutical Companies Shift to Near-Shore Medicines Sourcing as Supply Chain Risks Intensify
With global supply chains under stress due to COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. - December 16, 2021 - Pipelinepharma
IVI Opens Public Comment Period for Major Depressive Disorder Model Draft Protocol
Nonprofit Seeks Input Into Data Sources and Technical Specifications to Guide Model Development; Will Hold December 15 Webinar to Overview Protocol and Public Comment Process - December 14, 2021 - Innovation and Value Initiative
‘Dr. Pam’ Gumbs to be Showcased in the Winter Issue of P.O.W.E.R. Magazine as a Woman of Distinction
‘Dr. Pam’ Gumbs of Berkeley, California will be showcased in the Winter issue of P.O.W.E.R. Magazine as a Woman of Distinction for her outstanding achievements and contributions for over 40 years in the pharmaceutical field. Each quarter, P.O.W.E.R. chooses four exceptional women for... - December 09, 2021 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
Mirror Biologics, Inc. Announces Close of a $14 Million Financing Round
This Funding will be Used, in Part, to Launch an Asian Phase II/III Randomized Controlled Registration Trial for Advanced Liver Cancer in Q1/2-2022. - December 09, 2021 - Mirror Biologics, Inc.
PharmStars Announces 2021 Accelerator Graduates
12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. - December 08, 2021 - PharmStars
First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched
Scientific breakthroughs for kidney disease lead to the launch of the first-ever medical food for the daily dietary management of Polycystic Kidney Disease (PKD). - December 06, 2021 - Santa Barbara Nutrients
Parvus Therapeutics Announces Development and Manufacturing Agreement with Resilience to Advance Novel Autoimmune Drug Candidate PVT201
Parvus Therapeutics, a biopharmaceutical company developing Navacim™ platform-based disease-specific immunoregulator therapeutics to treat autoimmune diseases by activating endogenous generation of disease-specific regulatory T cells (Tregs) without impairing normal immune system function,... - November 29, 2021 - Parvus Therapeutics U.S., Inc.
7 Key Takeaways from SMi’s 10th Annual Pharmaceutical Microbiology Conference
SMi Reports: SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK. - November 28, 2021 - SAE Media Group
Navigating the Challenges and Legal Landscapes of Parallel Trade
SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade. - November 27, 2021 - SAE Media Group
LPA Statement Regarding Voxzogo™
Little People of America (LPA), the world’s oldest and largest support organization for people with dwarfism and their families, has been tracking biotechnical developments for the treatment of individuals with Achondroplasia. LPA President, Mark Povinelli, says, "With the FDA approval... - November 21, 2021 - Little People of America Inc.
Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles
Today Parvus announced it has entered into an agreement with Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO), for process development, scale-up and GMP manufacturing of NavacimTM nanoparticles, a key building block for all of our Navacim platform drug development candidates. - November 19, 2021 - Parvus Therapeutics U.S., Inc.
CANNA/Hemp Extraction Labs USA Announces Joint Venture Partnerships for Cannabis Cultivators/Growers and Cannapreneurs
CANNA/Hemp Extraction Labs USA (CHELUSA) announced today they are offering to finance and commission Cannabis Extraction Labs and Cannabis Cloning Labs in NM, NJ, AZ, IL, MT and VA. CHELUSA is looking to form strategic partnerships with Cultivators/Growers and Cannapreneurs in these key states. The... - November 18, 2021 - Hemp Extraction Labs USA
GENINVO Launches Centre of Excellence for Data Science and Analytics to Help Clients Unlock Insights Using Data Science
GENINVO, a leading provider of life sciences product and business solutions organization, announced the launch of a Centre of Excellence for Data Science and Analytics (DSA CoE). The DSA is a resolute team of experts comprising of life science and technology domains. Data Science and Analytics CoE... - November 18, 2021 - GenInvo, Inc.
PharmStars Announces Showcase Event for Inaugural Class
PharmStars, a pharma-focused accelerator for digital health startups, announces the start of its 2021 Showcase Event. At the Showcase Event, the 12 startups in the accelerator’s current cohort will pitch their digital health solutions to PharmStars’ pharma members. The startups and pharma members will also have the opportunity to meet privately to discuss potential partnership opportunities. - November 17, 2021 - PharmStars
Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease
Mirror Biologics, Inc., a private clinical stage biopharmaceutical company, today announces the issuance of US Patent No. 11,160,852, “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of therapeutic vaccines against cancers and infectious... - November 17, 2021 - Mirror Biologics, Inc.
Corinne E. Tobin, MD Joins New York Breast Imaging
New York Breast Imaging is pleased to announce the addition of Chief of Breast Imaging Corinne E. Tobin, MD, one of the most renowned and the first fellowship-trained breast imagers on Long Island. - November 15, 2021 - New York Breast Health
Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from Discovery to Healthcare
SMi Group reports: the 3rd Annual AI in Drug Discovery is set to return to London in March 2022 with a key focus on the opportunities of machine learning and AI in drug development - November 14, 2021 - SAE Media Group
Strategies Used by Seniors to Reduce Drug Costs Report Released by AAMSI
A significant share of U.S. seniors seek a way to reduce their cost for prescribed medications reports the American Association for Medicare Supplement Insurance. "Medicare's Open Enrollment ends in three weeks, a chance for seniors to see if they can get better drug plan coverage for the... - November 12, 2021 - American Association for Medicare Supplement Insurance
Eyecheck Announces FDA IND Clearance of STRI Formula, the First-Ever Food-Based, Combination Product in the STRI Phase 2 Clinical Trial for COVID-19 Symptoms
Eyecheck intends to initiate the Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial to evaluate STRI Formula in non-hospitalized adults with COVID-19. This trial is expected to begin in November 2021. - November 04, 2021 - Eyecheck, Inc.
PharmStars Welcomes Sumitovant Biopharma as Its Newest Member
PharmStars, the only pharma-focused, member-based accelerator for digital health startups, is pleased to announce that Sumitovant Biopharma has become its newest pharma member, joining existing members including Boehringer Ingelheim, Eli Lilly and Company, and Novo Nordisk. PharmStars focuses on bridging the "pharma-startup gap." PharmStars provides startups with education and mentoring to help them engage with pharma as clients and partners. - November 03, 2021 - PharmStars
SMi Group Launches Robotics & Automation in Pharma Conference 2022 in London, UK
SMi Group reports: the inaugural Robotics and Automation Conference is convening on 21st and 22nd February 2022, in London, UK, with a key focus on significant leaps in the robotic automation field. - November 01, 2021 - SAE Media Group
PharmD Live® Ends October’s American Pharmacists Month
PharmD Live®, the pharmacist-led telehealth company focused on reducing adverse drug effects, ended an active American Pharmacist Month with a full slate of new material regarding the importance of pharmacists to the healthcare system. “October was a wonderful celebration of hardworking... - October 31, 2021 - PharmD Live